Fri, Oct 24, 2014, 7:33 AM EDT - U.S. Markets open in 1 hr 57 mins

Recent

% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

  • patrizia.michael_alexander patrizia.michael_alexander Nov 8, 2013 10:53 AM Flag

    News Artcle

    Beverly Hills, CA (PRWEB) November 08, 2013

    An article published October 9, 2013, on CNN described the recent treatment of a patient living with permanent Bell’s palsy and Type I diabetes with IntelliCell Biosciences, Inc.’s stromal vascular fraction cells. Stromal vascular fraction cells (SVFC) are developed from adult autologous vascular cells derived from blood vessels. Babak Azizzadeh, MD, FACS, renowned Bell’s palsy and facial paralysis surgeon, says this patient’s experience may bring hope to others with permanent Bell’s palsy.

    “Bell’s palsy is a condition brought on by the activation of a virus that affects the facial nerve and causes facial paralysis on one side of the face. Generally, anti-viral and steroid medication will help the condition resolve over time, but some patients do experience permanent facial paralysis. For those patients, surgery is usually the only effective treatment,” explained Dr. Azizzadeh.

    The patient who was treated with the SVFC had undergone many unsuccessful treatments in the past, and was eventually given the new stem cell applications. He received two treatments 6 months apart. The patient experienced complete Bell’s palsy recovery and--as an unintended benefit—improvement of his diabetes condition. IntelliCell Biosciences is hopeful that its product will be revolutionary for the treatment of medical conditions that don't respond to traditional therapy, particularly Bell’s palsy.

    “It is important to address the side effects of permanent facial palsy in order to prevent the development of other conditions. For instance, patients with facial paralysis generally lose the ability to completely close the eye. If left untreated, this can cause severe eye damage. Currently, there are surgical options for treating incomplete eye closure, as well as facial reanimation surgeries to improve the patient’s appearance,” said Dr. Azizzadeh.

 
SVFC
0.00030.0000(0.00%)Oct 23 3:52 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.